(Q34178693)

31 July 2017

title

Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine (English)

1 reference

31 July 2017

1 reference

Peinado J

1

1 reference

31 July 2017

Hameg A

2

1 reference

31 July 2017

Garay RP

3

1 reference

31 July 2017

Bayle F

4

1 reference

31 July 2017

Nuss P

5

1 reference

31 July 2017

Dib M

6

1 reference

31 July 2017

publication date

23 January 2003

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

367

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

134-139

1 reference

5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity

31 July 2017

cites work

1 reference

12 December 2020

The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study

1 reference

12 December 2020

[Risperidone and concept of bipolar neuroleptic]

1 reference

12 December 2020

New insights into dopaminergic receptor function using antisense and genetically altered animals

1 reference

12 December 2020

Modulation of neurotransmitter release by presynaptic autoreceptors

1 reference

12 December 2020

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo

1 reference

12 December 2020

Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist

1 reference

12 December 2020

Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects

1 reference

12 December 2020

Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).

1 reference

12 December 2020

Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats

1 reference

12 December 2020

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

12 December 2020

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

1 reference

12 December 2020

Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

1 reference

12 December 2020

Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice

1 reference

12 December 2020

5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle

1 reference

12 December 2020

Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Olanzapine: an updated review of its use in the management of schizophrenia

1 reference

12 December 2020

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors

1 reference

12 December 2020

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used

1 reference

12 December 2020

Study of the pharmacological properties of 3-cyano-10-(3-dimethylamino-2-methylpropyl)-phenothiazine or cyamepromazine (R.P. 7.204)

1 reference

12 December 2020

Role of 5-HT(2C) receptors in the control of central dopamine function

1 reference

12 December 2020

Effects of 5-HT3 receptor agonists on voluntary ethanol intake in rats maintained on a limited access procedure

1 reference

12 December 2020

Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs

1 reference

12 December 2020

The role of serotonin in antipsychotic drug action

1 reference

12 December 2020

10.1007/S00210-002-0665-4

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1019863594

0 references

1 reference